<DOC>
	<DOCNO>NCT03024944</DOCNO>
	<brief_summary>The purpose project study brain image substance call tau , find brain person Alzheimer 's disease , use Tau binder , 18F-THK-5351 , live imaging tau brain . The main goal proposal study whether diabetes status ( type 2 diabetes [ refer diabetes ] pre-diabetes , compare normal glucose tolerance [ NGT ] ) , associate increase tau accumulation brain , one culprits Alzheimer 's disease , community-based group middle age Caribbean-Hispanics mean age 63 year . The investigator propose conduct tau positron emission tomography ( PET ) image 30 middle age Hispanics .</brief_summary>
	<brief_title>TAU PET Imaging Northern Manhattan Study Metabolism Mind</brief_title>
	<detailed_description>The burden late onset Alzheimer 's dementia ( LOAD ) antecedents increase without know prevention cure , diabetes seem one strongest risk factor . The predominate causal model Alzheimer 's disease ( AD ) research base amyloid hypothesis , posit amyloid ( A ) deposition brain cause synaptic dysfunction result early memory deficit progression mild cognitive impairment ( MCI ) dementia . Tau also gain increase interest AD pathology feature , biomarker , treatment target . There know curative preventive measure LOAD . One strong potential LOAD risk factor type 2 diabetes , abnormal elevation blood glucose associate microvascular macrovascular complication include cerebrovascular disease . Many study report association diabetes dementia , include LOAD vascular dementia ( VD ) . Most study find diabetes associate increase risk LOAD VD , strong association VD compare LOAD . Thus , study focus relation diabetes , pre-diabetes , elevate glucose , AD .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>All person undergo magnetic resonance imaging ( MRI ) amyloid PET already , prospectively deem eligible parent study cover protocol AAAQ2950 , approach participation . Person participate MRI amyloid PET protocol AAAQ2950</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Dementia</keyword>
	<keyword>THK</keyword>
</DOC>